Influenza outbreak

RECENT NEWS
Benzinga  Dec 12  Comment 
Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental biologics license application (sBLA) for Fluzone Intradermal Quadrivalent...
Forbes  Dec 5  Comment 
Flu season is taking off in the U.S. Over the last two weeks, I've seen an increasing number of feverish, achey, glassy-eyed patients testing positive for influenza A, most of whom were not vaccinated. My experience tracks well with the CDC's...
NPR  Dec 4  Comment 
The main flu strain circulating now tends to send more people to the hospital than other strains. It also causes more deaths, especially among the elderly, children and people with health issues.
The Hindu Business Line  Dec 1  Comment 
Hundreds of ducks floating on the vast sheets of the backwaters under the canopy of a blue sky. A half-clad, dark, lanky man on a small wooden canoe driving the cackling ducks with a long pole...
The Hindu Business Line  Nov 29  Comment 
China has confirmed a new human infection of the deadly H7N9 avian influenza virus, state news agency Xinhua said, the first case this winter in the southern province of Guangdong. ...
The Hindu Business Line  Nov 28  Comment 
Plea to prevail upon foreign govts against issuing travel advisories
GenEng News  Nov 26  Comment 
Scientists at the University of Buffalo report the development of a novel hybrid system that was designed to deliver vaccines that contain genetically engineered DNA to fight HIV, cancer, influenza, and other disorders. The team described its...
The Hindu Business Line  Nov 26  Comment 
Panic gripped Kerala’s poultry sales with a reported drop of 20-25 per cent following the detection of bird flu in central parts of the State.  The situation has brought down the rat...
The Economic Times  Nov 26  Comment 
Kerala has decided to cull about 2K poultry birds as a precautionary measure against H5 avian influenza virus, said Agriculture Minister KP Mohanan




 
TOP CONTRIBUTORS

Influenza, or the flu, is a common infectious disease, which can be deadly to individuals with compromised immune systems (the very young, the very old, and those with conditions such as AIDS or Cancer). However, occasionally particularly virulent strains of influenza break out that can be threatening on a much larger scale -- such as the flu epidemic of 1918 and, more recently, concerns that H5N1 "Bird Flu" or H1N1 "Swine Flu" could mutate into a highly-infectious and deadly virus. A number of pharmaceutical companies make treatments for the flu and benefit from the fear of a flu outbreak.


  • Roche Pharmaceuticals makes Tamiflu, an antiviral pill to treat the flu. In 2005, amid concerns that bird flu might pose a large threat during the winter flu season, many national governments began stocking up on Tamiflu. Chugai pharmaceuticals sells Tamiflu in Japan.
  • Novartis AG (NVS), through its acquisition of Chiron in 2006, supplies much of the traditional flu vaccine supply to the United States.
  • AstraZeneca (AZN), through recently acquired MedImmune, manufactures 'FluMist', a novel flu vaccine that is delivered via an intranasal spray rather than via an injection.

Companies with treatments for H1N1, or "Swine Flu"

In April 2009, a novel flu virus, known as "Swine Flu" because it was believed to have originated in pigs, started infecting humans. By April 28th, there were 1,300 confirmed cases of the flu, known by its scientific designation H1N1, in Mexico, and a handful in the U.S. and other parts of the world.

According to preliminary test done by the US Center for Disease Control, Roche Pharmaceuticals (RHHBY)'s Tamiflu and GlaxoSmithKline (GSK)'s Relenza are active against H1N1, although many older drugs are not. [1]

References

  1. Investors buy up shares of flu drug makers, New York Times, April 27th 2009.
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki